These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8060755)

  • 61. The central role of progesterone receptors and progestational agents in the management and treatment of breast cancer.
    Horwitz KB
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):14-9. PubMed ID: 3285481
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Human telomerase P53 estrogen and progesterone receptor expression in endometrial carcinoma].
    Dong Y; Li T; Liang Y; Zou WZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 36(1):61-5. PubMed ID: 14970891
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors.
    Pizer ES; Lax SF; Kuhajda FP; Pasternack GR; Kurman RJ
    Cancer; 1998 Aug; 83(3):528-37. PubMed ID: 9690546
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Estrogen receptors in the genital tract of the climacteric woman].
    Pérez-López FR; Campo López C
    Rev Med Univ Navarra; 1991; 36(4):17-31. PubMed ID: 1821057
    [No Abstract]   [Full Text] [Related]  

  • 67. Endometrial carcinomas: correlation between ER, PR, Ki67 status and histopathological prognostic parameters.
    Stoian SC; Simionescu C; Mărgăritescu C; Stepan A; Nurciu M
    Rom J Morphol Embryol; 2011; 52(2):631-6. PubMed ID: 21655654
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Panel of Villin, Pro-Ex-C, Estrogen Receptor and Progesterone Receptor Expressions Could Help in Differentiation Between Endocervical and Endometrioid Adenocarcinoma.
    Elfeky M; Harb O; Gertallah L
    Turk Patoloji Derg; 2017; 1(1):29-40. PubMed ID: 28832070
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ¹⁸F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcoma.
    Inoue K; Tsubamoto H; Kawata S; Hao H; Ikeda Y; Oku N; Hirota S
    J Obstet Gynaecol Res; 2014 Feb; 40(2):576-82. PubMed ID: 24118160
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic significance of p53, bcl-2 and EGFR in carcinoma of the endometrium.
    Athanassiadou P; Petrakakou E; Liossi A; Nakopoulou L; Zerva C; Dimopoulos A; Athanassiades P
    Acta Cytol; 1999; 43(6):1039-44. PubMed ID: 10578976
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasminogen activator inhibitors in endometrial adenocarcinoma.
    Gleeson NC; Gonsalves R; Bonnar J
    Cancer; 1993 Sep; 72(5):1670-2. PubMed ID: 8348499
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Estrogen replacement therapy and endometrial hyperplasia.
    Tsang P
    JAMA; 1996 Jun; 275(24):1880-1. PubMed ID: 8648861
    [No Abstract]   [Full Text] [Related]  

  • 73. Progestin therapy for perimenopausal women.
    Kase NG
    J Reprod Med; 1982 Aug; 27(8 Suppl):522-30. PubMed ID: 7131445
    [No Abstract]   [Full Text] [Related]  

  • 74. Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer.
    Proctor L; Pradhan M; Leung S; Cheng A; Lee CH; Soslow RA; Gilks CB; Talhouk A; McAlpine JM; Danielsen HE; Hoang LN
    Gynecol Oncol; 2017 Sep; 146(3):596-602. PubMed ID: 28647100
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
    Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
    J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women.
    Konishi I; Koshiyama M; Mandai M; Kuroda H; Yamamoto S; Nanbu K; Komatsu T; Matsushita K; Rao CV; Mori T
    Gynecol Oncol; 1997 May; 65(2):273-80. PubMed ID: 9159337
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Hyder SM; Murthy L; Stancel GM
    Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
    Moe BT; Vereide AB; Orbo A; Jaeger R; Sager G
    Anticancer Res; 2009 Apr; 29(4):1047-52. PubMed ID: 19414344
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hormone receptors in endometrial cancer.
    Gurpide E
    Cancer; 1981 Jul; 48(2 Suppl):638-41. PubMed ID: 7023668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.